Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of a H3R inverse agonist for the treatment of shift work disorder

Use of a H3R inverse agonist for the treatment of shift work disorder

US Patent 11369603 · Granted Jun 28, 2022

Estimated economic value: $39,474,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine recept2025
Use of mavoglurant in the reduction of alcohol use or in preventing relapse into2025
Use of mavoglurant in the reduction of cocaine use or in preventing relapse into2024
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine recep2022
Use of alpha 7 nicotinic acetylcholine receptor agonists2022
Use of alpha 7 nicotinic acetylcholine receptor agonists2022
Use of nicotinic acetylcholine receptor alpha 7 activators2021
Use of nicotinic acetylcholine receptor alpha 7 activators2020
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine recep2017